Uterine Fibroid US Market Top Key Players – Cook Medical Inc. (US), Boston Scientific Corporation (US), GE Healthcare (U.K.) and Forecast to 2022

US Uterine Fibroid Market

Description

WiseGuyReports.Com adds” U.S. Uterine Fibroid Market Research Report - Forecast to 2022 “Research To Its Database.

Uterine Fibroids are the abnormal growth that gets developed inside or on the wall of a woman’s uterus. These are also known as leiomyoma or myomas. These are noncancerous growths that cause symptoms such as heavy bleeding between or during the menstrual cycle, pain in pelvis or lower back, increased menstrual cramping, swelling enlargement of the abdomen. Increasing prevalence due to heredity and rising number of treatments to cure this disease has fuelled the growth of this market.  

U.S. Uterine Fibroid Market has been segmented on the basis of type which comprises of Subserosal Fibroids, Intramural Fibroids, Submucosal Fibroids and others. On the basis of diagnosis the market is segmented into Medical Resonance Imaging (MRI) scanners, Computed tomography (CT), Ultrasounds and others. On the basis of treatment the market is segmented into Uterine Fibroid Embolization, Magnetic Resonance Guided Focused Ultrasound, Myolysis, Endometrial Ablation, Hysterectomy and Myomectomy. 

The U.S. Market for Uterine Fibroids is expected to reach USD 39,993.2 million by the end of the forecasted period and is expected to grow at a CAGR of 3.24%.

Key Players
Some of the key players in this market are: AstraZeneca (England), Cook Medical Inc. (US), Boston Scientific Corporation (US), GE Healthcare (U.K.), AbbVie Inc. (U.S.), Hologic (U.S.), and others.

 

Get sample Report @  https://www.wiseguyreports.com/sample-request/1201697-u-s-uterine-fibroid-market-research-report-forecast-to-2022

Study Objectives: 
Ø To provide insights about factors, influencing and affecting the market growth.
Ø To provide historically and forecast revenue of the market segments and sub-segments with respect to regional markets and their countries.
Ø To provide historical and forecast revenue of the market segments based on types, diagnosis, and treatment.
Ø To provide strategic profiling of key players in the market, comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market.

Target Audience
• Uterine Fibroid Devices and Drug Manufacturers
• Uterine Fibroid Devices and Drug Suppliers
• Private Research Laboratories
• Research and Development (R&D) Companies
• Market Research and Consulting Service Providers
• Medical Research Laboratories

Key Finding
• The U.S. Uterine Fibroid market and is expected to reach USD 39,993.2 million by 2022.
• By Type, Intramural Fibroids holds the largest market share of U.S. uterine fibroid market and is expected to reach USD 14,972.5 million by 2022.
• By Treatment, hysterectomy holds the largest market share of U.S. uterine fibroid market and is expected to reach USD 8,042.3 million by 2022. 

The reports also cover country level analysis:
America
• North America
Europe
Western Europe
• Germany
• France
• Italy
• Spain
• UK
• Rest of Western Europe
• Eastern Europe
Asia
• China
• India
• Japan
• South Korea
• Rest of Asia
Middle East & Africa

Enquiry About Report @ https://www.wiseguyreports.com/enquiry/1201697-u-s-uterine-fibroid-market-research-report-forecast-to-2022

 

Table of Contents -Major Key Points

1.1.1 Prevalence of the Uterine Fibroids in U.S. 8

2 Scope of Study 10
2.1 Research Objective 10
2.2 Assumptions & Limitations 10
2.2.1 Assumptions 10
2.2.2 Limitations 10

2.3 Market Structure 11

3 Research Methodology 12
3.1 Primary Research 13
3.2 Secondary Research 13

4 U.S. Uterine Fibroid Market 15
4.1 Introduction 15
4.2 U.S. Uterine Fibroid Market, By Type 17
4.3 U.S. Uterine Fibroid Market, By Diagnosis 19
4.4 U.S. Uterine Fibroid Market, By Treatment 21

5 Company Profile 29
5.1 AstraZeneca 29
5.1.1 Company Overview 29
5.1.2 Product overview 29
5.1.3 Financial Overview 30
5.1.4 Key Development 31
5.1.5 SWOT Analysis 32
5.2 Cook Medical Inc. 33
5.2.1 Overview 33
5.2.2 Product Overview 33
5.2.3 Financials 33
5.2.4 Key Developments 33
5.2.5 SWOT Analysis 34
5.3 Boston Scientific Corporation 35
5.3.1 Company Overview 35
5.3.2 Product/Business Segment Overview 35
5.3.3 Financial Overview 35
5.3.4 Key Development 36
5.3.1 SWOT Analysis 37
5.4 GE Healthcare 38
5.4.1 Company Overview 38
5.4.2 Product/Business Segment Overview 38
5.4.3 Financial Overview 38
5.4.4 Key Development 40
5.4.5 SWOT Analysis 40
5.5 AbbVie Inc. 41
5.5.1 Company Overview 41
5.5.2 Product/Business Segment Overview 41
5.5.3 Financial Overview 41
5.5.4 Key Development 43
5.5.5 SWOT Analysis 43
5.6 Hologic, Inc. 44
5.6.1 Company Overview 44
5.6.2 Product/Business Segment Overview 44
5.6.3 Financial Overview 44
5.6.4 Key Development 46
5.6.5 SWOT Analysis 46

………..CONTINUE

About Us

Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, Industry research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.

NORAH TRENT

Partner Relations & Marketing Manager

sales@wiseguyreports.com

www.wiseguyreports.com

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)             

This release was published on openPR.